AAAAAA

   
Results: 1-9 |
Results: 9
TcRho1, a farnesylated Rho family homologue from Trypanosoma cruzi
Authors: Nepomuceno-Silva, JL Yokoyama, K de Mello, LDB Mendonca, SM Paixao, JC Baron, R Faye, JC Buckner, FS Van Voorhis, WC Gelb, MH Lopes, UG
Citation: Jl. Nepomuceno-silva et al., TcRho1, a farnesylated Rho family homologue from Trypanosoma cruzi, J BIOL CHEM, 276(32), 2001, pp. 29711-29718
IL-6 promoter is modulated by the 24 kDda FGF-2 isoform fused to the hormone binding domain of the oestrogen receptor
Authors: Delrieu, I Chinestra, P Delassus, F Bayard, F Prats, H Faye, JC
Citation: I. Delrieu et al., IL-6 promoter is modulated by the 24 kDda FGF-2 isoform fused to the hormone binding domain of the oestrogen receptor, CYTOKINE, 12(7), 2000, pp. 1110-1114
Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS)
Authors: Poirot, M De Medina, P Delarue, F Perie, JJ Klaebe, A Faye, JC
Citation: M. Poirot et al., Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS), BIO MED CH, 8(8), 2000, pp. 2007-2016
RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: Evidenced in vivo by an anti-farnesyl cysteine antibody
Authors: Baron, R Fourcade, E Lajoie-Mazenc, I Allal, C Couderc, B Barbaras, R Favre, G Faye, JC Pradines, A
Citation: R. Baron et al., RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: Evidenced in vivo by an anti-farnesyl cysteine antibody, P NAS US, 97(21), 2000, pp. 11626-11631
Estrogens and atherosclerosis: recent data and future
Authors: Arnal, JF Elhage, R Maret, A Rami, J Faye, JC Bayard, F
Citation: Jf. Arnal et al., Estrogens and atherosclerosis: recent data and future, M S-MED SCI, 15(2), 1999, pp. 212-218
Inhibition of interleukin-6 promoter activity by the 24 kDa isoform of fibroblast growth factor-2 in HeLa cells
Authors: Delrieu, I Faye, JC Bayard, F Maret, A
Citation: I. Delrieu et al., Inhibition of interleukin-6 promoter activity by the 24 kDa isoform of fibroblast growth factor-2 in HeLa cells, BIOCHEM J, 340, 1999, pp. 201-206
Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor
Authors: Kedjouar, B Daunes, S Vilner, BJ Bowen, WD Klaebe, A Faye, JC Poirot, M
Citation: B. Kedjouar et al., Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor, BIOCH PHARM, 58(12), 1999, pp. 1927-1939
Modifications of benzylphenoxy ethanamine antiestrogen molecules: Influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity
Authors: Delarue, F Kedjouar, B Mesange, F Bayard, F Faye, JC Poirot, M
Citation: F. Delarue et al., Modifications of benzylphenoxy ethanamine antiestrogen molecules: Influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity, BIOCH PHARM, 57(6), 1999, pp. 657-661
Alternative initiation of translation accounts for a 67/45 kDa dimorphism of the human estrogen receptor ER alpha
Authors: Barraille, P Chinestra, P Bayard, F Faye, JC
Citation: P. Barraille et al., Alternative initiation of translation accounts for a 67/45 kDa dimorphism of the human estrogen receptor ER alpha, BIOC BIOP R, 257(1), 1999, pp. 84-88
Risultati: 1-9 |